ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract

Hirota, William K.; Zuckerman, Marc J.; Adler, Douglas G.; Davila, Raquel E.; Egan, James; Leighton, Jonathan A.; Qureshi, Waqar; Rajan, Elizabeth; Fanelli, Robert D.; Wheeler-Harbaugh, Jo; Baron, Todd H.; Faigel, Douglas O.

doi:10.1016/j.gie.2006.02.004

Cited by 475 publications

(291 citation statements)

References 152 publications

Supporting

Mentioning

265

Contrasting

Unclassified

Order By: Relevance

“…The guidelines from major gastrointestinal societies published between 2002 and 2008 specify a 3-year surveillance interval for nondysplastic Barrett's esophagus (NDBE) [4][5][6]. In part because of recent data indicating a lower-than-expected risk of adenocarcinoma arising from Barrett's epithelium [7], more recent guidelines have extended the surveillance interval to 3-5 years.…”

Section: Introductionmentioning

confidence: 99%

Adherence to Surveillance Guidelines in Nondysplastic Barrett’s Esophagus

Dalal

Coffing

Imperiale

2018

Journal of Clinical Gastroenterology

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Adherence to Surveillance Guidelines in Nondysplastic Barrett’s Esophagus

Dalal

Coffing

Imperiale

2018

Journal of Clinical Gastroenterology

View full text Add to dashboard Cite

show abstract

“…Therefore, it is a correct approach to consider these lesions as premalignant esophageal pathologies. Endoscopic follow-up at intervals of 1-3 years is recommended in many premalignant esophageal pathologies, depending on the presence of dysplasia or other risk factors (14). However, as the number of cases is very limited and also the presence of patients who are diagnosed with malignant melanoma two years after the diagnosis of melanocytosis, we believe that the endoscopic follow-up should not be longer than one year (12).…”

Section: Discussionmentioning

confidence: 99%

An unusual localization: Esophageal melanocytosis

Kozan¹,

Tatar²

2018

Turk J Surg

View full text Add to dashboard Cite

Esophageal melanocytosis is a rare clinical and pathological condition characterized by non-atypical melanocytic proliferation and increased melanin in the esophageal mucosa, which is normally histologically non-melanocytic. Intensive melanin accumulation and hyperpigmentation are necessary for endoscopic recognition. Due to the fact that it is a rare gastrointestinal system pathology, experience and knowledge about its diagnosis, treatment, and course are also limited. Although it is argued that chronic stimulating factors have an influence, there is no clear information about its etiology and pathogenesis. Malignant melanomas and melanocytic nevi in particular come to the fore in the differential diagnosis. Opinions and findings indicating that melanocytosis may be a precursor for malignant melanomas make the diagnosis and follow-up of this clinical and pathological condition more important. In this article, a patient with esophageal melanocytosis diagnosed by endoscopic evaluation is presented, with the aim of increasing the awareness of clinicians, especially endoscopists and pathologists, on this subject.

show abstract

“…Nevertheless, patients with high-grade dysplasia confirmed at least two gastrointestinal pathologists should undergo surgical or endoscopic resection because of the high probability of coexisting or metachronous invasive carcinoma [88].…”

Section: Dysplasiamentioning

confidence: 99%